PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | Patent Publication Number 20220233505

US 20220233505 A1
Patent Number-
Application Number17659216
Filled DateApr 14, 2022
Priority DateNov 21, 2011
Publication DateJul 28, 2022
Original Assignee
Current AssigneeAllergan
Inventor/ApplicantsMohammed I. Dibas
John E. Donello
Daniel W. Gil
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.